Clarivate Q2 Misses Revenue Slightly, Beats on EPS; Reaffirms 2026 Outlook; CFO Transition Announced
CLVT sits 39% above its 52-week low of $1.66.
Summary
Clarivate reported Q2 2026 results with a slight revenue miss and an adjusted EPS beat, reaffirmed its full-year outlook, and announced a CFO transition.
Key Events · Earnings and Guidance · CLVT
-
Q2 Revenue Miss, EPS Beat
Revenue of $587.3M missed the $589.7M consensus by less than 1%, while adjusted EPS of $0.19 beat by a penny.
-
Non-Cash Goodwill Impairment
Net loss of $268.6M included a $221.7M non-cash goodwill impairment charge related to the LS&H divestiture.
-
Full-Year 2026 Outlook Reaffirmed
Management reaffirmed guidance: ACV organic growth 2-3%, recurring organic revenue growth 0.75-2.25%, adjusted EBITDA $980M-$1.04B, adjusted diluted EPS $0.70-$0.80.
-
CFO Transition
Michael Easton appointed EVP & CFO, replacing Jonathan Collins. Easton is an internal successor with over 25 years of experience, previously at IHS Markit.
Analysis · CLVT · Technology
Clarivate's Q2 revenue of $587.3M missed consensus by less than 1%, while adjusted EPS of $0.19 beat by a penny. The net loss of $268.6M was driven entirely by a non-cash goodwill impairment charge tied to the LS&H divestiture. Management reaffirmed full-year 2026 guidance, signaling confidence in the Value Creation Plan. The CFO transition from Jonathan Collins to Michael Easton adds a leadership change to watch, though the appointment of an internal successor suggests continuity.
At the time of this filing, CLVT was trading at $2.31 on NYSE in the Technology sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $1.66 to $4.77. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.